NEW YORK (GenomeWeb) – CareDx reported after the close of the market on Monday that its preliminary first quarter revenues would be in the range of $11.4 million to $11.6 million, up 73 percent to 76 percent, respectively, from $6.6 million in Q1 2016.

Also on Monday, the firm received a notification letter from Nasdaq stating that it is out of compliance with a rule requiring timely filing of periodic reports with the US Securities and Exchange Commission. The firm received the notice because it had not filed its Form 10-Q for Q1 in the required time.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.